Life After Bilski: How the Limited Holding of Bilski v. Kappos Has Been Interpreted, Stretched, and Otherwise Twisted to Conform to Various Views

Please join your peers for a roundtable discussion that will dissect the legal implications of the Supreme Court’s decision in Bilski v. Kappos. During this interactive program, attendees will translate the case into workable strategies to help patentees both survive in the post-Bilski world and explore new avenues to attack already-granted patents.

Topics to Be Discussed

• Which claiming strategies have been used as alternatives to Bilski-type claims? 
• What litigation strategies have been implemented for invalidity challenges? 
• What impact has Bilski had on the § 101 case law? 
• Given the Supreme Court Mayo v. Prometheus grant, vacatur, and remand (GVR) in light of Bilski, will the Federal Circuit in Prometheus II sustain diagnostic method claims?

Featured Guests
James D. Smith, Associate General Counsel and Chief IP Counsel, Baxter Healthcare Corporation
Matthew J. Kelly, Managing Director – Chief IP Counsel, CME Group

Foley Participants
Jonathan R. Spivey, IP Litigation Partner
Andrea M. Augustine, IP Litigation Partner
George C. Best, IP Litigation Partner
Harold C. Wegner, Intellectual Property Partner